Chemo Causes Lasting Physical Decline In Breast Cancer Survivors
By Dennis Thompson HealthDay Reporter
TUESDAY, March 4, 2025 -- Breast cancer survivors treated with chemotherapy tend to suffer a longer-lasting decline in their physical health, compared to women who receive hormone therapy or other cancer treatments.
Chemotherapy patients reported a physical decline that extended more than two years after their diagnosis with breast cancer, researchers reported Feb. 28 in JAMA Network Open.
This decline included fatigue and reduced ability to carry out daily activities like walking, climbing stairs or carrying groceries, researchers said.
“If they do not receive chemotherapy, it is unlikely that they will have long-lasting physical health decline,” lead researcher Clara Bodelon, senior principal scientist of survivorship research at the American Cancer Society, said in a news release.
“This is encouraging news for breast cancer survivors,” she said.
For the study, researchers analyzed data on more than 2,500 women diagnosed with breast cancer, comparing them to more than 12,800 women without cancer.
“Patients with breast cancer suffer from an abundance of long-term and late health effects and are at risk of earlier onset disease and higher incidence of chronic health conditions,” Bodelon said.
About 48% of women with breast cancer received hormone-blocking therapy, 11% received chemotherapy, and 25% received both, researchers said.
Results showed a greater physical decline within two years of diagnosis for those breast cancer survivors who got hormone therapy, chemo or both, when compared to women without cancer.
However, the physical decline among hormone therapy patients was restricted solely to women treated with aromatase inhibitors, researchers found.
Those drugs lower estrogen levels by stopping an enzyme in fat tissue from changing other hormones into estrogen.
In addition, physical decline extended out more than two years only in women who received chemotherapy, the study says.
“These findings are important because understanding factors related to their physical health decline could lead to interventions to improve their health outcomes,” Bodelon said.
“However, further studies are needed to confirm these results and to better understand the health consequences of these treatments,” she concluded.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-03-05 00:00
Read more

- FDA Approves More Broadly Protective Meningococcal Vaccine
- Muscle-Building Supplements Tied to Muscle Dysmorphia Symptomatology
- NIH-Funded Clinical Trial Will Evaluate New Dengue Therapeutic
- Few Individuals With Mental, Substance Use Disorders Receive Guideline-Consistent Treatment
- Seroprevalence of HPAI A(H5) Identified in Bovine Veterinary Practitioners
- Black Maternal Deaths Remain High Despite Overall Decline In U.S.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions